Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease

ObjectiveUrsodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effect...

Full description

Bibliographic Details

Published in:	Frontiers in Cellular and Infection Microbiology
Main Authors:	Yanyan Li, Na Zhu, Xinyu Cui, Yingying Lin, Xin Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Subjects:	coronavirus disease 2019 severe acute respiratory syndrome coronavirus-2 ursodeoxycholic acid chronic liver disease infection propensity score matching analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1178590/full